*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Doxercalciferol is a synthetic prodrug of vitamin D2 used to manage secondary hyperparathyroidism in chronic kidney disease. Manufactured via enzymatic or chemical hydroxylation, its molecular formula is <strong>C<sub>28</sub>H<sub>44</sub>O<sub>2</sub></strong> and CAS number is <strong>169605-12-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Nephrology:</strong> Oral administration for suppressing parathyroid hormone (PTH) elevation.</li>
<li><strong>Dialysis Centers:</strong> Standard therapy for patients on hemodialysis or peritoneal dialysis.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> API sourcing for tablet and capsule formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in cases of hypersensitivity or existing hypercalcemia. Strictly store below 25°C in light-resistant containers. Clinical use requires regular monitoring of serum calcium and phosphorus levels to prevent toxicity.</p>